logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kenji Morimoto

Kyoto Prefectural University of Medicine
H指数:27
被引数:4,300

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR-mutant NSCLC After TKI Resistance

EGFR突变非小细胞肺癌TKI耐药后，癌症恶病质预测免疫治疗联合化疗的获益

Anticancer Research
IF1.7
2026-05-010
PRE
Nakatani, Haruka; Kawachi, Hayato; Yamada, Tadaaki; Furuya, Naoki; Tanaka, Hisashi; Yoshimura, Akihiro; Oba, Tomohiro; Hibino, Makoto; Fukuda, Takahito; Goto, Yasuhiro; Nakao, Akira; Ogusu, Shinsuke; Okazaki, Yuta; Harada, Taishi; Ota, Takayo; Masubuchi, Ken; Mikami, Koji; Hata, Tae; Morimoto, Kenji; Takayama, Koichi
AXL–SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL–SHC1信号轴介导了HER2-aberrant肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药。

npj Precision Oncology
IF8
2026-04-020
OAAI
Masaki Ishida; Tadaaki Yamada; Yuki Katayama; Hayato Kawachi; Ryo Sawada; Ryota Nakamura; Soichi Hirai; Yohei Matsui; Kenji Morimoto; Keisuke Onoi; Aosa Nakamura-Sasada; Mano Horinaka; Toshiyuki Sakai; Tomoki Sakakida; Toshifumi Doi; Kazuo Yasumoto; Yasuhiro Goto; Naoki Furuya; Hirokazu Taniguchi; Hirokazu Ogino; Nakano Takayuki; Yusuke Chihara; Koji Fukuda; Hiroaki Taniguchi; Hisanori Uehara; Seiji Yano; Shinsaku Tokuda; Koichi Takayama
Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database

使用整合的临床试验数据库研究脆弱性对局部晚期非小细胞肺癌患者同步放化疗结局的影响

Therapeutic Advances in Medical Oncology
IF4.2
2026-01-170
PRE
Kenji Morimoto; Tadaaki Yamada; Naoya Nishioka; Nobuyuki Yamamoto; Seiji Niho; Isamu Okamoto; Katsuyuki Hotta; Hiroaki Okamoto; Shunichi Sugawara; Toshio Shimokawa; Yuichi Ozawa; Satoshi Oizumi; Koichi Takayama
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study

EGFR突变非小细胞肺癌在EGFR-TKI治疗失败后，化疗免疫疗法批准前后真实世界治疗结局：一项日本队列研究

international journal of oncology
IF2.8
2025-07-220
PRE
Kenji Morimoto; Tadaaki Yamada; Naoki Furuya; Hisashi Tanaka; Akihiro Yoshimura; Tomohiro Oba; Makoto Hibino; Takahito Fukuda; Yasuhiro Goto; Akira Nakao; Shinsuke Ogusu; Yuta Okazaki; Taishi Harada; Takayo Ota; Ken Masubuchi; Koji Mikami; Tae Hata; Shoki Matsumoto; Ryoichi Honda; Koji Date; Yusuke Chihara; Koichi Takayama
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure

EGFR突变亚型对EGFR-TKI失败后非小细胞肺癌对化疗免疫疗法和化疗反应的影响

TARGETED ONCOLOGY
IF4
2025-04-240
PRE
Morimoto, Kenji; Furuya, Naoki; Tanaka, Hisashi; Yoshimura, Akihiro; Oba, Tomohiro; Hibino, Makoto; Fukuda, Takahito; Goto, Yasuhiro; Nakao, Akira; Ogusu, Shinsuke; Okazaki, Yuta; Harada, Taishi; Ota, Takayo; Masubuchi, Ken; Mikami, Koji; Hata, Tae; Matsumoto, Shoki; Honda, Ryoichi; Date, Koji; Chihara, Yusuke; Kawachi, Hayato; Takayama, Koichi
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
ONCOIMMUNOLOGY
IF6.3
2024-12-160
OAAI
Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi
Depth of response and treatment outcomes of immune checkpoint inhibitor-based therapy in patients with advanced non-small cell lung cancer and high PD-L1 expression: An exploratory analysis of retrospective multicenter cohort
INVESTIGATIONAL NEW DRUGS
IF2.7
2024-08-210
PRE
Tachibana, Yusuke; Morimoto, Kenji; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-08-010
OAAI
Kataoka, Nobutaka; Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Yamada, Takahiro; Hiranuma, Osamu; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Takayama, Koichi
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study
FRONTIERS IN IMMUNOLOGY
IF5.9
2024-07-150
OAAI
Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells

AXL信号介导KRAS G12C-mutant肿瘤细胞对KRAS G12C抑制剂的适应性耐药

CANCER LETTERS
IF10.1
2024-04-010
OAAI
Morimoto, Kenji; Yamada, Tadaaki; Hirai, Soichi; Katayama, Yuki; Fukui, Sarina; Sawada, Ryo; Tachibana, Yusuke; Matsui, Yohei; Nakamura, Ryota; Ishida, Masaki; Kawachi, Hayato; Kunimasa, Kei; Sasaki, Takaaki; Nishida, Makoto; Furuya, Naoki; Watanabe, Satoshi; Shiotsu, Shinsuke; Nishioka, Naoya; Horinaka, Mano; Sakai, Toshiyuki; Uehara, Hisanori; Yano, Seiji; Son, Bo-Kyung; Tokuda, Shinsaku; Takayama, Koichi
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-03-010
OA
Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Fujii, Hiroyuki; Morita, Satomi; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Hiranuma, Osamu; Yamada, Takahiro; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Iwasaku, Masahiro; Tokuda, Shinsaku; Tanaka, Noriyuki; Miyagawa-Hayashino, Aya; Takayama, Koichi
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%

免疫检查点抑制剂联合化疗对TPS ≥ 50% 的老年非小细胞肺癌PD-L1预后的影响

FRONTIERS IN IMMUNOLOGY
IF5.9
2024-02-232
OAAI
Takei, Shota; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study

不适合III期放化疗的非小细胞肺癌患者放疗后durvalumab治疗的2期试验: spiri-rt研究

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-12-013
OA
Yamada, Tadaaki; Goto, Yasuhiro; Tanaka, Hiroshi; Kimura, Hideharu; Minato, Koichi; Gyotoku, Hiroshi; Honda, Takeshi; Watanabe, Satoshi; Morimoto, Kenji; Kiyomi, Fumiaki; Uchino, Junji; Takayama, Koichi
Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status
TARGETED ONCOLOGY
IF4
2023-10-302
PRE
Morimoto, Kenji; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Nishioka, Naoya; Katayama, Yuki; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi

研究方向

暂未获取到该数据
T
Tadaaki Yamada
H 指数:41论文数:563被引数:6,301
K
Koichi Takayama
H 指数:75论文数:954被引数:1.9万
S
Shinsaku Tokuda
H 指数:19论文数:120被引数:1,582
M
Masahiro Iwasaku
H 指数:24论文数:135被引数:1,900
S
Shinsuke Shiotsu
H 指数:17论文数:121被引数:1,397
Y
Yuki Katayama
H 指数:17论文数:88被引数:1,123
Y
Yusuke Chihara
H 指数:23论文数:157被引数:3,155
T
Takayuki Takeda
H 指数:22论文数:196被引数:2,738
H
Hayato Kawachi
H 指数:16论文数:152被引数:1,120
Y
Yasuhiro Gotô
H 指数:31论文数:334被引数:3,805